Európska únia - estónčina - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , kolmekordne kombineeritud ravi) lisandina toitumise ja treeningu patsientidel, ebapiisavalt kontrollitud nende maksimaalne talutav annus metformiin ja sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Európska únia - estónčina - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 erinevate kombinatsioonide kohta kättesaadavate andmete osas).

Estónsko - estónčina - Ravimiamet

aurobindo pharma limited - metformiin - õhukese polümeerikattega tablett - 1000mg 90tk; 1000mg 180tk; 1000mg 50tk; 1000mg 60tk; 1000mg 100tk; 1000mg 20tk; 1000mg 70tk; 1000mg 40tk; 1000mg 80tk

Estónsko - estónčina - Ravimiamet

sandoz pharmaceuticals d.d. - metformiin - õhukese polümeerikattega tablett - 1000mg 30tk; 1000mg 180tk; 1000mg 90tk; 1000mg 200tk; 1000mg 60tk; 1000mg 120tk; 1000mg 100tk; 1000mg 20tk

Estónsko - estónčina - Ravimiamet

teva pharma b.v. - metformiin - õhukese polümeerikattega tablett - 1000mg 50tk; 1000mg 120tk; 1000mg 100tk; 1000mg 30tk; 1000mg 60tk; 1000mg 84tk; 1000mg 90tk; 1000mg 15tk

Estónsko - estónčina - Ravimiamet

aurobindo pharma limited - metformiin - õhukese polümeerikattega tablett - 850mg 90tk; 850mg 56tk; 850mg 180tk; 850mg 200tk; 850mg 60tk; 850mg 30tk; 850mg 100tk; 850mg 70tk; 850mg 500tk; 850mg 120tk; 850mg 50tk; 850mg 42tk; 850mg 20tk

Estónsko - estónčina - Ravimiamet

aurobindo pharma limited - metformiin - õhukese polümeerikattega tablett - 500mg 28tk; 500mg 400tk; 500mg 500tk; 500mg 84tk; 500mg 60tk; 500mg 30tk; 500mg 50tk; 500mg 90tk; 500mg 98tk; 500mg 70tk; 500mg 42tk; 500mg 300tk; 500mg 56tk; 500mg 200tk; 500mg 20tk; 500mg 100tk; 500mg 40tk

Estónsko - estónčina - Ravimiamet

accord healthcare b.v. - metformiin - õhukese polümeerikattega tablett - 1000mg 30tk; 1000mg 200tk; 1000mg 90tk; 1000mg 100tk

Estónsko - estónčina - Ravimiamet

accord healthcare b.v. - metformiin - õhukese polümeerikattega tablett - 500mg 120tk; 500mg 100tk; 500mg 50tk; 500mg 30tk; 500mg 1000tk; 500mg 7tk; 500mg 400tk

Estónsko - estónčina - Ravimiamet

accord healthcare b.v. - metformiin - õhukese polümeerikattega tablett - 850mg 90tk